Media CoverageNovember 20, 2024BillionToOne named the Diagnostics Company of the Year by BioTech Breakthrough AwardsRead
Press ReleasesNovember 12, 2024Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid GrowthRead
Media CoverageSeptember 27, 2024The Green Room Podcast from Obstetrics & Gynecology-Interview with Jennifer Hoskovec, MS, author of “Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.”Read
Media CoverageSeptember 17, 2024A Major Addition to Austin’s Life Science Ecosystem with the Expansion of BillionToOneRead
Press ReleasesSeptember 5, 2024Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland CapitalRead
Press ReleasesJuly 26, 2024BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen GenotypingRead